Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
about
Neoadjuvant chemotherapy followed by surgery in gastric cancer patients with extensive lymph node metastasisPotential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational studyCombination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysisMulticenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck.Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer.Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma.Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study.Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX).A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.Preliminary trial of surgery after chemotherapy for advanced gastric cancer with peritoneal dissemination.Preliminary trial of adjuvant surgery for advanced gastric cancer.Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer.
P2860
Q26775081-2CCE3AD0-6A3B-44C9-B629-1CD7C74668F0Q33612711-81FDEE71-C14A-4F01-A69D-3E39DEF4F34CQ33912151-761F2A74-E485-43CD-8BCF-8D50D701213BQ34623415-C7F0EEA1-A7AD-4CEB-99EF-73BA7A6D758DQ35710296-6F7FCF62-6460-4B89-861B-9A7D3F8031B7Q36403236-3F74444C-8EE7-42BD-82F8-8E82EBC90259Q37644000-84644B6A-2E61-471E-9068-37EA89584C4BQ37689109-42A1C1AA-9A8C-44FF-9F13-8CE604C15E31Q38864811-5134DFB2-7F51-4589-A444-C4DA535CD541Q41889228-481C2AE8-EFE1-4348-AC14-341B87A34136Q42323722-444DB6BE-794D-49D1-A12B-A15ABC96DA60Q46616879-37CB7744-D032-4B14-9BE0-7170BCFF6EC7Q50999929-2856947D-001F-4F00-94ED-7D65212648FFQ55551032-960EB972-BD8F-4073-98B9-30BFCF4F7C7C
P2860
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@en
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@nl
type
label
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@en
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@nl
prefLabel
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@en
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@nl
P2093
P1433
P1476
Feasibility and efficacy of pr ...... -aortic lymph node metastases.
@en
P2093
Jun Kinoshita
Katsunobu Oyama
Sachio Fushida
Takashi Fujimura
Tetsuo Ohta
Yasumichi Yagi
P304
P356
10.1097/CAD.0B013E32832EC02B
P577
2009-09-01T00:00:00Z